Cannell & Co. Gilead Sciences, Inc. Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cannell & Co. holds 4,225 shares of GILD stock, worth $354,139. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,225

Previous 4,425 4.52%

Holding current value

$354,139

Previous $331,000 3.32%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $14,654 - $16,618	-200 Reduced 4.52%	4,225 $342,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $36,970 - $40,335	-500 Reduced 10.15%	4,425 $331,000
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $6,232 - $8,947	-100 Reduced 1.99%	4,925 $422,000
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $56,563 - $64,609	-950 Reduced 15.9%	5,025 $310,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $3,244 - $3,682	50 Added 0.84%	5,975 $434,000
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $30,148 - $32,941	475 Added 8.72%	5,925 $408,000
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $14,100 - $16,088	-235 Reduced 4.13%	5,450 $352,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $11,896 - $13,555	210 Added 3.84%	5,685 $331,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $938,510 - $1.2 Million	-14,985 Reduced 73.24%	5,475 $409,000
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $26,804 - $29,484	435 Added 2.17%	20,460 $1.33 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $23,441 - $25,875	-375 Reduced 1.84%	20,025 $1.27 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $144,157 - $161,655	-2,330 Reduced 10.25%	20,400 $1.38 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $955,083 - $1.07 Million	-15,274 Reduced 40.19%	22,730 $1.48 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $652,379 - $851,304	-10,776 Reduced 22.09%	38,004 $2.38 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $78,051 - $86,417	-1,095 Reduced 2.2%	48,780 $3.77 Million
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $178,744 - $208,498	2,755 Added 5.85%	49,875 $3.53 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $277,520 - $338,328	-3,810 Reduced 7.48%	47,120 $3.55 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $1.54 Million - $1.8 Million	-21,605 Reduced 29.79%	50,930 $3.65 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $5.23 Million - $6.2 Million	72,535	72,535 $5.88 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account